GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Gross-Profit-to-Asset %

Jinhe Biotechnology Co (SZSE:002688) Gross-Profit-to-Asset % : 12.86% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Jinhe Biotechnology Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥710 Mil. Jinhe Biotechnology Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥5,522 Mil. Therefore, Jinhe Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 12.86%.


Jinhe Biotechnology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Jinhe Biotechnology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Gross-Profit-to-Asset % Chart

Jinhe Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.56 18.74 17.49 14.32 12.90

Jinhe Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.66 12.75 13.81 11.43 12.86

Competitive Comparison of Jinhe Biotechnology Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Jinhe Biotechnology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinhe Biotechnology Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinhe Biotechnology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Jinhe Biotechnology Co's Gross-Profit-to-Asset % falls into.



Jinhe Biotechnology Co Gross-Profit-to-Asset % Calculation

Jinhe Biotechnology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=642.498/( (4508.51+5453.807)/ 2 )
=642.498/4981.1585
=12.90 %

Jinhe Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=710.268/( (5453.807+5589.5)/ 2 )
=710.268/5521.6535
=12.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Jinhe Biotechnology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinhe Biotechnology Co (SZSE:002688) Business Description

Traded in Other Exchanges
N/A
Address
Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023
Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.
Executives
Wang Zhi Jun Directors, executives
Liu Ying Chun Executives
Deng Yi Xin Secretary Dong
Li Fu Zhong Director
Liu Yun Tian Directors, executives
Xie Chang Xian Directors, executives
Wang Dong Xiao Director
Yao Jian Xiong Supervisors
Zheng Liu Ji Supervisors
Niu You Shan Executives
Wu Ming Xia Director
Li Wei Qi Directors, executives
Wu Rui Gang Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines